ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Gyre Therapeutics Inc

Gyre Therapeutics Inc (GYRE)

12.08
0.04
(0.33%)
Closed July 02 4:00PM
12.08
0.00
(0.00%)
After Hours: 6:35PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
12.08
Bid
12.10
Ask
12.90
Volume
48,441
11.50 Day's Range 12.45
5.88 52 Week Range 30.40
Market Cap
Previous Close
12.04
Open
11.88
Last Trade
8
@
12.1
Last Trade Time
Financial Volume
$ 579,976
VWAP
11.9728
Average Volume (3m)
78,036
Shares Outstanding
85,510,116
Dividend Yield
-
PE Ratio
-11.04
Earnings Per Share (EPS)
-1.09
Revenue
113.45M
Net Profit
-92.93M

About Gyre Therapeutics Inc

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop val... Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Gyre Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GYRE. The last closing price for Gyre Therapeutics was $12.04. Over the last year, Gyre Therapeutics shares have traded in a share price range of $ 5.88 to $ 30.40.

Gyre Therapeutics currently has 85,510,116 shares outstanding. The market capitalization of Gyre Therapeutics is $1.03 billion. Gyre Therapeutics has a price to earnings ratio (PE ratio) of -11.04.

GYRE Latest News

Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia

SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on...

Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology

SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibrotic therapeutics for a...

Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension

SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibrotic therapeutics for a...

Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes

SAN DIEGO, May 28, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibrotic therapeutics for a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.6716.042267050910.4112.8798.924632511.56603098CS
41.4513.64063969910.6312.8798.99425211.34339583CS
12-4.79-28.393598103116.8717.258.97803613.16124392CS
26-13.43-52.646021168225.5127.458.98093215.90913904CS
525.0872.5714285714730.45.889145417.27988376CS
1565.0872.5714285714730.45.889145417.27988376CS
2605.0872.5714285714730.45.889145417.27988376CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDZNRoadzen Inc
$ 2.95
(82.10%)
107.99M
SYTSYLA Technologies Company Ltd
$ 3.05
(59.69%)
6.19M
VSVersus Systems Inc
$ 1.90
(43.94%)
58.92M
VIVKVivakor Inc
$ 3.41
(36.95%)
727.57k
MEDSTRxADE HEALTH Inc
$ 18.585
(30.70%)
397.65k
MAXNMaxeon Solar Technologies Ltd
$ 0.18
(-67.20%)
173.82M
RNACCartesian Therapeutics Inc
$ 15.7715
(-35.02%)
1.45M
EFTReFFECTOR Therapeutics Inc
$ 0.18
(-32.56%)
1.63M
DTSSDatasea Inc
$ 3.43
(-30.57%)
1.15M
ARDXArdelyx Inc
$ 5.29
(-30.12%)
22.67M
NVDANVIDIA Corporation
$ 122.67
(-1.31%)
220.35M
TSLATesla Inc
$ 231.26
(10.20%)
205.03M
MAXNMaxeon Solar Technologies Ltd
$ 0.18
(-67.20%)
173.82M
SQQQProShares UltraPro Short QQQ
$ 7.88
(-2.96%)
114.55M
RDZNRoadzen Inc
$ 2.95
(82.10%)
107.99M

Your Recent History

Delayed Upgrade Clock